• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Modi Cabinet approves 100% FDI in medical devices sector via automatic route

Share:

April 1, 2019

Existing conditions and prior approval required in case of merger and acquisition done away with

The Central government has approved 100 per cent foreign direct investment in the medical devices sector via automatic route. The approval was given by the Union Cabinet, headed by Prime Minister Narendra Modi, on Wednesday.

Medical devices come under the pharma sector in which 100 per cent FDI through automatic route is permitted only in case of new ventures. Approval of Foreign Investment Promotion Board is needed in the case of brownfield investment—acquisition of existing companies.

At present, the medical devices sector is subjected to FDI limits and other conditions such as mandatory government nods as in the case of brownfield investments in the pharma sector. But the new policy does away with this distinction in the medical devices sector.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

For long, industry has been demanding opening the medical device industry for FDI through automatic route, saying there are no big firms for medical devices in India, and so there is no threat of merger or acquisition.

Experts say more than 75 per cent of medical devices come from other countries. The worth of medical devices industry in the country is estimated at US $7 billion.
Medical devices include a wide range of products, such as sutures, implants and surgical instruments.

The move is expected to help attract more investments and boost the domestic manufacturing.

Date: DowntoEarth

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Medable Launches TeleConsent for Clinical Trials to Streamline Approvals During Decentralized TrialsMedable Launches TeleConsent for Clinical Trials to Streamline Approvals During Decentralized Trials
  • KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp.KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp.
  • AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan NotesAbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes
  • Takeda signs $50m deal with French biotech EnteromeTakeda signs $50m deal with French biotech Enterome
  • Retractable Technologies, Inc. Reports Private Stock RepurchaseRetractable Technologies, Inc. Reports Private Stock Repurchase
  • South Jersey medical-device company exploring ‘strategic alternatives’South Jersey medical-device company exploring ‘strategic alternatives’
  • Philips and BioIntelliSense Integrate to Enhance Remote Patient MonitoringPhilips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring
  • Novartis Secures Second Phase III PNH Win in as Many MonthsNovartis Secures Second Phase III PNH Win in as Many Months

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications